These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11710196)

  • 1. Bisphenol A and its biomaterial monomer derivatives alteration of in vitro cytochrome P450 metabolism in rat, minipig, and human.
    Cannon JM; Kostoryz E; Russo KA; Smith RE; Yourtee DM
    Biomacromolecules; 2000; 1(4):656-64. PubMed ID: 11710196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision-cut rat liver slices.
    Pfeiffer E; Metzler M
    Arch Toxicol; 2004 Jul; 78(7):369-77. PubMed ID: 15114436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Arch Toxicol; 1998 Jun; 72(7):387-94. PubMed ID: 9708877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo.
    Thapliyal R; Maru GB
    Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples.
    Anzenbacher P; Soucek P; Anzenbacherová E; Gut I; Hrubý K; Svoboda Z; Kvĕtina J
    Drug Metab Dispos; 1998 Jan; 26(1):56-9. PubMed ID: 9443853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of drug-metabolizing enzyme activity in human hepatic cytochrome P450s by bisphenol A.
    Niwa T; Tsutsui M; Kishimoto K; Yabusaki Y; Ishibashi F; Katagiri M
    Biol Pharm Bull; 2000 Apr; 23(4):498-501. PubMed ID: 10784435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats.
    Narimatsu S; Mochida M; Matsumoto T; Masubuchi Y; Horie T; Nagata K; Funae Y; Cho AK; Suzuki T
    Chem Biol Interact; 1996 Sep; 101(3):207-24. PubMed ID: 8870689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
    Olesen OV; Linnet K
    Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes.
    Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
    Chemosphere; 2000 Oct; 41(7):973-8. PubMed ID: 10879814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo DNA adduct formation by bisphenol A.
    Atkinson A; Roy D
    Environ Mol Mutagen; 1995; 26(1):60-6. PubMed ID: 7641708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
    Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency.
    Yoshihara S; Mizutare T; Makishima M; Suzuki N; Fujimoto N; Igarashi K; Ohta S
    Toxicol Sci; 2004 Mar; 78(1):50-9. PubMed ID: 14691209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.
    VandenBranden M; Ring BJ; Binkley SN; Wrighton SA
    Pharmacogenetics; 1996 Feb; 6(1):81-91. PubMed ID: 8845864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol-A content of resin monomers and related degradation products.
    Schmalz G; Preiss A; Arenholt-Bindslev D
    Clin Oral Investig; 1999 Sep; 3(3):114-9. PubMed ID: 10803121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
    Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.
    Elsby R; Maggs JL; Ashby J; Park BK
    J Pharmacol Exp Ther; 2001 Apr; 297(1):103-13. PubMed ID: 11259533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17.
    Niwa T; Fujimoto M; Kishimoto K; Yabusaki Y; Ishibashi F; Katagiri M
    Biol Pharm Bull; 2001 Sep; 24(9):1064-7. PubMed ID: 11558570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.